Not yet recruiting

4

10

 

Venetoclax + Azacitidine +HAG

The People's Hospital of Jiaozuo City; The People's Hospital of Jiaozuo City, Beijing Medical Award Foundation

Relapse/Refractory Acute Myeloid Leukemia

 

 

Completed

4

31

 

VAA regimen

the First Affiliated Hospital of Zhejiang University School of Medicine; the First Affiliated Hospital of Zhejiang University School of Medicine, self-funded

Acute myeloid leukemia

 

 

Recruiting

4

50

 

venetocax ;venetocax ;venetocax ;venetocax

Beijing Children's Hospital, Capital Medical University; Beijing Children's Hospital, Capital Medical University, Capital Health Development Research Project (No. 2022-1-20191)

Acute myeloid leukemia (AML)

 

 

Recruiting

4

53

 

Venetoclax+HAG solution

The First Affiliated Hospital, Zhejiang University College of Medicine; The First Affiliated Hospital, Zhejiang University College of Medicine, Self-raised

Early precursor T-cell acute lymphoblastic leukemia

 

 

Not yet recruiting

4

20

 

azacytidine plus low dose venetoclax

Beijing Hospital; Beijing Hospital, self-funded

acute myeloid leukemia

 

 

Recruiting

4

20

 

Venetoclax-based regimen

Beijing Children's Hospital, Capital Medical University; Beijing Children's Hospital, Capital Medical University, Capital Health and Development of Special Grant

pediatric acute leukemia

 

 

Recruiting

4

28

 

venetoclax + azacitidine

The First Affiliated Hospital of Zhejiang University Medical College; The First Affiliated Hospital, College of Medicine, Zhejiang University, Research funding

Myelodysplastic Syndrome

 

 

Recruiting

4

118

RoW

Venetoclax, Allogeneic transplant

He Huang

Acute Myeloid Leukemia

12/27

02/28

Not yet recruiting

4

172

RoW

Cladribine, 2-CdA, CdA, Cytarabine, Ara-C, G-CSF, Filgrastim, Granulocyte Colony-stimulating Factor, Venetoclax, Venclexta

Nanfang Hospital, Southern Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou No.12 People's Hospital, Guangzhou Panyu Central Hospital, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou First People's Hospital, Foresea Life Insurance Guangzhou General Hospital, Guangdong Second Provincial General Hospital, Jiangmen Central Hospital, Shantou Central Hospital, Maoming People's Hospital, First Affiliated Hospital of Guangxi Medical University, Hainan General Hospital, Dongguan People's Hospital, Tungwah Hospital of Sun Yat-Sen University, Shenzhen Hospital of Southern Medical University, Central People's Hospital of Zhanjiang, ZhuHai Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, LiuZhou People's Hospital, First People's Hospital of Foshan, Southern Medical University, China, Affiliated Hospital of Guangdong Medical University, Guilin Medical University, China, Yuebei People's Hospital, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Guangzhou Medical University, Peking University Shenzhen Hospital

Relapsed/Refractory AML

06/25

12/25

Not yet recruiting

4

52

 

Standard-dose Decitabine (DEC) combined with Venetoclax (VEN)

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

myeloproliferative chronic myelomonocytic leukemia

 

 

Not yet recruiting

4

48

 

venetoclax combined with azacytidine

The First Affiliated Hospital of Zhejiang University; Zhejiang Provincial Hospital of Chinese Medicine, None

Chronic myelomonocytic leukemia

 

 

Recruiting

4

100

RoW

Venetoclax, Azacitidine

AbbVie

Acute Myeloid Leukemia

11/27

11/27

Recruiting

4

67

 

Ixazomib; Venetoclax; Pomalidomide; Dexamethasone

The Second Hospital of Hebei Medical University; The Second Hospital of Hebei Medical University, None

multiple myeloma

 

 

Recruiting

4

60

 

Oral venetoclax ;Without venetoclax

Handan Central Hospital; Handan Central Hospital, Self-paying

Acute myeloid leukemia

 

 

Not yet recruiting

4

816

 

The combination of targeted therapy and chemotherapy was applied in the treatment of reduction of volume, induction therapy, consolidation therapy and maintenance therapy, and venetoclax combined with RIF in maintenance period; The combination of targeted therapy and chemotherapy was applied in the treatment of reduction of volume, induction therapy, consolidation therapy and maintenance therapy, and only Venetoclax in maintenance period

Beijing Children's Hospital, Capital Medical University; Beijing Children's Hospital, Capital Medical University, self-raised

Acute myeloid leukemia in children

 

 

Not yet recruiting

4

20

 

Mitoxantrone hydrochloride liposome+standard-dose cytarabine+venetoclax

The First Affiliated Hospital, College of Medicine, Zhejiang University; The First Affiliated Hospital, College of Medicine, Zhejiang University, CSPC OUYI PHARMACEUTICAL CO., LTD.

Relapsed/Refractory Acute Myeloid Leukemia

 

 

Not yet recruiting

4

60

 

all-trans retinoic acid, decitabine and venetoclax; none

The Third People’s Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University; The Third People’s Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Anti-Cancer Association Clinical Research (HENGRUI) Funding General Project of Sichuan Province (XH2023 3012)

acute myeloid leukemia

 

 

Not yet recruiting

4

30

 

Mitoxantrone hydrochloride liposome injection combined with azacitidine and venetoclax (MAV)

The First Affiliated Hospital of Army Medical University; The First Affiliated Hospital of Army Medical University, Subject of your choice (self-supporting)

Acute myeloid leukemia

 

 

Recruiting

4

114

 

Venetoclax in combination with azacitidine for the maintenance treatment of post-remission AML

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Self-financing

Acute myeloid leukemia (AML)

 

 

Not yet recruiting

4

40

 

mitoxantrone hydrochloride liposome+venetoclax+azacitidine

General Hospital of Chinese People's Liberation Army Northern Theater Command; General Hospital of Chinese People's Liberation Army Northern Theater Command, self-financed

Acute Myeloid Leukemia

 

 

Not yet recruiting

4

100

 

Liposomal mitoxantrone combined with venetoclax and azacitidine; venetoclax combined with azacitidine.

Tongji Hospital Affiliated to Tongji Medical College Huazhong University of Science and Technology; Tongji Hospital Affiliated to Tongji Medical College Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College Huazhong University of Science and Technology

acute myeloid leukemia